Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby

T.S. Barnes, L.A. Hinds, David Jenkins, G.T. Coleman, A.L. Colebrook, C.T. Kyngdon, C.G. Gauci, M.W. Lightowlers

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In Australia, macropodids are common intermediate hosts for the cestode Echinococcus granulosus, and sylvatic transmission is maintained via wild dogs. The parasite causes mortality in a number of macropodid species and the sylvatic cycle provides a source of infection to domestic livestock and humans. We determined the efficacy of the hydatid vaccine, EG95 in the tammar wallaby, Macropus eugenii, challenging either 1 or 9 months post-vaccination. EG95 provides similar protection to that seen in sheep (96'100%). Control tammars were significantly more likely to become infected (odds ratio 29.44; CI 4.13, 209.97; P=0.001) and to develop more cysts (count ratio 26.69; CI 5.83, 122.19; P<0.001). The vaccination may be beneficial if administered pre-release in captive breeding programmes for endangered macropodids. Further work to develop oral delivery methods may enable vaccine administration of wild animals and thereby a reduction in sylvatic transmission.
Original languageEnglish
Pages (from-to)461-468
Number of pages8
JournalParasitology
Volume136
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint Dive into the research topics of 'Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby'. Together they form a unique fingerprint.

  • Cite this

    Barnes, T. S., Hinds, L. A., Jenkins, D., Coleman, G. T., Colebrook, A. L., Kyngdon, C. T., Gauci, C. G., & Lightowlers, M. W. (2009). Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby. Parasitology, 136(4), 461-468. https://doi.org/10.1017/S0031182009005526